Your account is not claimed yet. You can sign up with ORCID to claim your account.

Giacomo Pellegrini

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 9

Top Venues

Healthcare (Basel, Switzerland)

International journal of environmental research and public health

American journal of hematology

Pharmaceuticals (Basel, Switzerland)

Fondazione Floriani

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione Floriani Mar 1o 2015

Italy

Researcher

Publications

Gianfrancesco Fiorini, Giacomo Pellegrini, Matteo Franchi, Angela Ida Pincelli, Antonello Emilio Rigamonti, Giovanni Corrao, Alessandro Sartorio, Silvano Gabriele Cella
Pharmacological Treatment of Type-2-Diabetes and Cardiovascular Comorbidities: Differences between Undocumented Migrants and Natives in Italy. Healthcare (Basel, Switzerland) 11 (1) (2022)
Marco Salvini, Camilla Damonte, Lorenzo Mortara, Fabrizio Maggi, Antonino Bruno, Giacomo Pellegrini, Barbara Mora, Marco Brociner, Alessia Ingrassia, Roberta Mattarucchi, Benedetta Bianchi, Davide Sirocchi, Stefania Agnoli, Elisa Rumi, Michele Merli, Alessandro Fossati, Susanna Bassi, Raffaella Bombelli, Matteo Gallazzi, Oscar Borsani, Andreina Baj, Matteo Franchi, Paolo A Grossi, Francesco Passamonti
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients. American journal of hematology 97 (8) (2022)
Gianfrancesco Fiorini, Giacomo Pellegrini, Matteo Franchi, Angela Ida Pincelli, Antonello Emilio Rigamonti, Giovanni Corrao, Alessandro Sartorio, Silvano Gabriele Cella
Pharmacological Treatment of Type-2-Diabetes and Cardiovascular Comorbidities: Differences between Undocumented Migrants and Natives in Italy. Healthcare (Basel, Switzerland) 11 (1) (2022)
Matteo Franchi, Giacomo Pellegrini, Giovanni Corrao
Effectiveness and Cost-Effectiveness Profile of Second-Line Treatments with Nivolumab, Pembrolizumab and Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Gianfrancesco Fiorini, Giacomo Pellegrini, Matteo Franchi, Angela Ida Pincelli, Antonello Emilio Rigamonti, Giovanni Corrao, Alessandro Sartorio, Silvano Gabriele Cella
Pharmacological Treatment of Type-2-Diabetes and Cardiovascular Comorbidities: Differences between Undocumented Migrants and Natives in Italy. Healthcare (Basel, Switzerland) 11 (1) (2022)
Gianlorenzo Scaccabarozzi, Matteo Crippa, Emanuele Amodio, Giacomo Pellegrini
Assessing the Costs of Home Palliative Care in Italy: Results for a Demetra Multicentre Study. Healthcare (Basel, Switzerland) 10 (2) (2022)
Luca Riva, Augusto Caraceni, Federico Vigorita, Jacopo Berti, Maria Pia Martinelli, Matteo Crippa, Giacomo Pellegrini, Gianlorenzo Scaccabarozzi
COVID-19 emergency and palliative medicine: an intervention model'. BMJ supportive & palliative care (2020)
Gianlorenzo Scaccabarozzi, Emanuele Amodio, Luca Riva, Oscar Corli, Marco Maltoni, Grazia Di Silvestre, Adriana Turriziani, Piero Morino, Giacomo Pellegrini, Matteo Crippa
Clinical Care Conditions and Needs of Palliative Care Patients from Five Italian Regions: Preliminary Data of the DEMETRA Project. Healthcare (Basel, Switzerland) 8 (3) (2020)
Oscar Corli, Giacomo Pellegrini, Cristina Bosetti, Luca Riva, Matteo Crippa, Emanuele Amodio, Gianlorenzo Scaccabarozzi
Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study. International journal of environmental research and public health 17 (22) (2020)

Giacomo Pellegrini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Giacomo Pellegrini